Overview

Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica

Status:
Not yet recruiting

Trial end date:
2026-01-30

Target enrollment:

Participant gender:

Summary

This will be efficacy and safety of Induction and Tapering Therapy with Tofacitinib and Glucocorticoid in patients with Polymyalgia Rheumatica (ITTG PMR): An open-label 52-week randomized controlled trial

Phase:

Phase 3

Details

Lead Sponsor:

Zhejiang University

Treatments:

Prednisone
Tofacitinib